Acute Lymphoblastic Leukemia

Cancer Cytogenetics

Volumn , Issue , 2010, Pages 233-296

  Harrison, Christine J ^a   Johansson, Bertil ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Acute lymphoblastic leukemia; Basophilic cytoplasm; Central nervous system; Cytomorphologic features; Gene expression

Indexed keywords

EID: 84886341242     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118010136.ch9     Document Type: Chapter

References (278)

1. Aguiar RC, Sohal J, Van Rhee F, Carapeti M, Franklin IM, Goldstone AH, Goldman JM, Cross NC (1996): TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. M.R.C. Adult Leukaemia Working Party. Br J Haematol 95:673-677.
2. Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R, Karran EL, Brown DG, Cain K, Harder L, Gesk S, Martin-Subero JI, Atherton MG, Bruggemann M, Calasanz MJ, Davies T, Haas OA, Hagemeijer A, Kempski H, Lessard M, Lillington DM, Moore S, Nguyen-Khac F, Radford-Weiss I, Schoch C, Struski S, Talley P, Welham MJ, Worley H. Strefford JC, Harrison CJ, Siebert R, Dyer MJ (2007): Five members of the CEBP transcription factor family are targeted by recurrent 1GH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109:3451-3461.
3. Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C, Garand R, Lafage-Pochitaloff M, Delabesse E, Buzyn A, Troussard X, Maclntyre E (2003): CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRyS lineage. Blood 102:1000-1006.
4. Asnafi V, Beldjord K, Libur M, Villarese P, Millien C, Ballerini P, Kuhlein E, Lafage-Pochitaloff M, Delabesse E, Bernard O, Maclntyre E (2004): Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 104:4173-4180.
5. Attarbaschi A, Mann G, Konig M, Dworzak MN, Trebo MM, Muhlegger N, Gadner H, Haas OA (2004): Incidence and relevance of secondary chromosome abnormalities in childhood TEL/ AML1 + acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia 18:1611-1616.
6. Attarbaschi A, Mann G, Konig M, Steiner M, Dworzak MN, Gadner H, Haas OA (2006): Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases. Genes Chromosomes Cancer 45:608-611.
7. Attarbaschi A, Mann G, Strehl S, Konig M, Steiner M, Jeitler V, Lion T, Dworzak MN, Gadner H, Haas OA (2007): Deletion of 1 Iq23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 21:584-586.
8. Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M, van den Akker J, Perot C, Pellegrino B, Landman-Parker J, Douay L, Berger R, Bernard OA (2002): HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 100:991-997.
9. Ballerini P, Busson M, Fasola S, van den Akker J, Lapillonne H, Romana SP, Marynen P, Bernard OA, Landman-Parker J, Berger R (2005): NUP214-ABLI amplification in t(5; 14)/HOX 1 lL2-positive ALL present with several forms and may have a prognostic significance. Leukemia 19:468-470.
10. Barber KE, Ford AM, Harris RL, Harrison CJ, Moorman AV (2004a): MLL translocations with concurrent 3' deletions: interpretation of FISH results. Genes Chromosomes Cancer 41:266-271.
11. Barber KE, Martineau M, Harewood L, Stewart M, Cameron E, Strefford JC, Rutherford S, Allen TD, Broadfield ZJ, Cheung KL, Harris RL, Jalali GR, Moorman AV, Robinson HM, Harrison CJ (2004b): Amplification of the ABL gene in T-cell acute lymphoblastic leukemia. Leukemia 18:1153-1156.
12. Barber KE, Harrison CJ, Broadfield ZJ, Stewart AR, Wright SL, Martineau M, Strefford JC, Moorman AV (2007): Molecular cytogenetic characterization of TCF3 (E2A)/I9p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 46:478-486.
13. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Smith RG, Baer R (1995): Does activation of the TALI gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood 86:666-676.
14. Behrendt H, Charrin C, Gibbons B, Harrison CJ, Hawkins JM, Heerema NA, Horschler-Botel B, Huret JL, Lai JL, Lampert F (1995): Dicentric (9; 12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study group. Leukemia 9:102-106.
15. Bellido M, Aventin A, Lasa A, Estivill C, Camicer MJ, Pons C, Matias-Guiu X, Bordes R, Baiget M, Sierra J, Nomdedeu JF (2003): Id4 is deregulated by a t(6; I4)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia. Haematologica 88:994-1001.
16. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, Van't Veer MB (1995): Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783-1786.
17. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976): Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33:451 -458.
18. Berger R, Bernheim A (1985): Cytogenetics of Burkitt's lymphoma-leukaemia: a review. IARC Sci Publ 65-80.
19. Berger R, Dastugue N, Busson M, van den AJ, Perot C, Ballerini P, Hagemeijer A, Michaux L, Charrin C, Pages MP, Mugneret F, Andrieux J, Talmant P, Helias C, Mauvieux L, Lafage-Pochitaloff M, Mozziconacci MJ, Cornillet-Lefebvre P, Radford I, Asnafi V, Bilhou-Nabera C, Nguyen KF, Leonard C, Speleman F, Poppe B, Bastard C, Taviaux S, Quilichini B, Herens C, Gregoire MJ, Cave H, Bernard OA (2003): t(5;14)/HOXl lL2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia 17:1851-1857.
20. Bergeron J, Clappier E, Cauwelier B, Dastugue N, Millien C, Delabesse E, Beldjord K, Speleman F, Soulier J, Maclntyre E, Asnafi V (2006): HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation. Leukemia 20:1184-1187.
21. Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D (1991): Two site-specific deletions and t(l;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-l gene. Oncogene 6:1477-1488.
22. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Delia V V, Monni R, Nguyen KF, Mercher T, Penard-Lacronique V, Pasturaud P, Gressin L, Heilig R, Daniel MT, Lessard M, Berger R (2001): A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hoxl 1L2 gene in T acute lymphoblastic leukemia. Leukemia 15:1495-1504.
23. Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cave H (2003): CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 37:44_57.
24. Beverloo HB, Le Coniat M, Wijsman J, Lillington DM, Bernard O, de Klein A, v Wering E, Welborn J, Young BD, Hagemeijer A, Berger R (1995): Breakpoint heterogeneity in t(10; 11) translocations in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization. Cancer Res 55:4220-4224.
25. Biondi A, Cimino G, Pieters R, Pui CH (2000): Biological and therapeutic aspects of infant leukemia. Blood 96:24-33.
26. Biondi A, Rizzari C, Valsecchi MG, De LP, Arico M, Basso G, Locatelli F, Lo NL, De RG, Masera G (2006): Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Haematologica 91:534-537.
27. Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A (1997): Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Blood 90:571-577.
28. Brown L, Cheng JT, Chen Q, Siciliano MJ, Crist W, Buchanan G, Baer RJ (1990): Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J 9:3343-3351.
29. Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, Bennett JM (2001): Precursor B-cell and T-cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, pp 109-117.
30. Burmeister T, Gokbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S (2006): NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood 108:3556-3559.
31. Burnett RC, Thirman MJ, Rowley JD, Diaz MO (1994): Molecular analysis of the T-cell acute lymphoblastic leukemia- associated t(l;7)(p34;q34) that fuses LCK and TCRB. Blood 84:1232-1236.
32. Busson-Le Coniat M, Nguyen KF, Daniel MT, Bernard OA, Berger R (2001): Chromosome 21 abnormalities with AMLI amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer 32:244-249.
33. Byatt SA, Cheung KL, Lillington DM, Mazzullo H, Martineau M, Bennett C, Roberts K, Harewood L, Sumption N, Humphreys M, Burrett J, Harrison CJ (2001): Three further cases of t(8;14)(ql 1.2; q32) in acute lymphoblastic leukemia. Leukemia 15:1304-1305.
34. Callen DF, Raphael K, Michael PM, Garson OM (1989): Acute lymphoblastic leukemia with a hypodiploid karyotype with less than 40 chromosomes: the basis for division into two subgroups. Leukemia 3:749-752.
35. Carroll AJ, Crist WM, Parmley RT, Philips C, Krischer J, Head D, Gresik M, Ravindranath Y, Weinstein HJ (1984): Pre-B cell leukemia as sociated with chromosome translocati on 1; 19. Blood 63:721-726.
36. Carroll A, Castelberry R, Crist W (1987 a): Lack of association between abnormalities of the short arm of chromosome 9 and either lymphomatous features of T cell phenotype in childhood acute lymphoblastic leukemia. Blood 69:735-738.
37. Carroll AJ, Raimondi SC, Williams DL, Behm FG, Borowitz M, Castleberry RP, Harris MB, Patterson RB, PullenDJ, Crist WM (1987b): tdic(9; 12): a nonrandom chromosome abnormality in childhood B- cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood 70:1962-1965.
38. Carroll AJ, Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, Buchanan GR, Wimmer RS, Vietti TJ (1990): The t(l;14)(p34;ql 1) is nonrandom and restricted to T-cell acute lymhoblastic leukemia: a pediatric oncology group study. Blood 76:1220-1224.
39. Carter TL, Watt PM, Kumar R, Burton PR, Reaman GH, Sather HN, Baker DL, Kees UR (2001): Hemizygous pl6(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood 97:572-574.
40. Cauwelier B, Dastugue N, Cools J, Poppe B, Herens C, De PA, Hagemeijer A, Speleman F (2006): Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRbeta locus rearrangements and putative new T-cell oncogenes. Leukemia 20:1238-1244.
41. Cauwelier B, Cave H, Gervais C, Lessard M, Barin C, Perot C, van den AJ, Mugneret F, Charrin C, Pages MP, Gregoire MJ, Jonveaux P, Lafage-Pochitaloff M, Mozzicconacci MJ, Terre C, Luquet I, Cornillet-Lefebvre P, Laurence B, Plessis G, Lefebvre C, Leroux D, ntoine-Poirel H, Graux C, Mauvieux L, Heimann P, Chalas C, Clappier E, Verhasselt B, Benoit Y, Moerloose BD, Poppe B, Van RN, Keersmaecker KD, Cools J, Sigaux F, Soulier J, Hagemeijer A, Paepe AD, Dastugue N, Berger R, Speleman F (2007): Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia 21:121-128.
42. Cave H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A, Malet M, Boutard P, Benoit Y, Mauvieux L, Lutz P, Mechinaud F, Grardel N, Mazingue F, Dupont M, Margueritte G, Pages MP, Bertrand Y, Plouvier E, Brunie G, Bastard C, Plantaz D, Vande V, I, Hagemeijer A, Speleman F, Lessard M, Otten J, Vilmer E, Dastugue N (2004): Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 103:442-450.
43. Cazzaniga G, Daniotti M, Tosi S, Giudici G, Aloisi A, Pogliani E, Kearney L, Biondi A (2001): The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. Cancer Res 61:4666-^670.
44. Chapiro E, Russell L, Radford-Weiss L Bastard C, Lessard M, Cave H, Fert-Ferrer S, Barin C, Maarek O, Delia-Valle V, Strefford JC, Berger R, Harrison CJ, Bernard OA, Nguyen-Khac F (2006): Overexpression of CEBPA resulting from the translocation t(14; 19)(q32;q 13) of human precursor B acute lymphoblastic leukemia. Blood 10:3560-3563.
45. Charrin C, Thomas X, Ffrench M, Le QH, Andrieux J, Mozziconacci MJ, Lai JL, Bilhou-Nabera C, Michaux L, Bernheim A, Bastard C, Mossafa H, Perot C, Maarek O, Boucheix C, Lheritier V, Delannoy A, Fiere D, Dastugue N (2004): A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL). Blood 104:2444-2451.
46. Chen CS, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH (1993): Molecular rearrangements on chromosome 1 Iq23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 81:2386-2393.
47. Chessells JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM (1997): Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol 99:93-100.
48. Chessells JM. Harrison CJ, Watson SL, Vora AJ, Richards SM (2002): Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999. Br J Haematol 117:306-314.
49. Chilcote RR, Brown E, Rowley JD (1985): Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N. Engl J Med 313:286-291.
50. Chim CS, Wong AS, Kwong YL (2003): Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann Hemalol 82:738-742.
51. CiminoC Lo CF, Biondi A, Elia L, Luciano A, Croce CM, Masera G, Mandelli F, Canaani E (1993): ALL-1 gene at chromosome 11 q23 is consistently altered in acute leukemia of early infancy. Blood 82:544-546.
52. Clappier E, Cuccuini W, Cayuela JM, Vecchione D, Baruchel A, Dombret H, Sigaux F, Soulier J (2006): Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia 20:82-86.
53. Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayuela JM, Dik WA, Langerak AW, Montpellier B, Nadel B, Walrafen P, Delattre O, Aurias A, Leblanc T, Dombret H, Gewirtz AM, Baruchel A, Sigaux F, Soulier J (2007): The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 110:1251-1261.
54. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON (1988): Unique forms of the abl tyrosine kinase distinguish Ph'-positive CML from Ph'-positive ALL. Science 239:775-777.
55. Clark R, Byatt SA, Bennett CF, Brama M, Martineau M, Moorman AV, Roberts K, Seeker-Walker LM, Richards S, Eden OB, Goldstone AH, Harrison CJ (2000): Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia 14:241-246.
56. Cooley LD, Chenevert S, Shuster JJ, Johnston DA, Mahoney DH, Carroll AJ, Devidas M, Linda SB, Lauer SJ, Camitta BM (2007): Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Cancer Genet Cytogenet 175:117-124.
57. Croce CM, Tsobe M, Palumbo A, Puck J, Ming J, Tweardy D, Erikson J, David M, Rovera G (1985): Gene for alpha-chain of human T-cell receptor: location of chromosome 14 region involved in T-cell neoplasms. Science 227:1044-1047.
58. D'Achille P, Seymour JF, Campbell LJ (2006): Translocation (14; 18)(q32;q21) in acute lymphoblastic leukemia: a study of 12 cases and review of the literature. Cancer Genet Cytogenet 171:52-56.
59. Davidsson J, Andersson A, Paulsson K, Heidenblad M, lsaksson M, Borg A, Heldrup J, Behrendtz M, Panagopoulos 1, Fioretos T, Johansson B (2007): Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(Iq) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in lq22-32.3. Hum Mol Genet 16:2215-2225.
60. De Keersmaecker K, Graux C, Odero MD, Mentens N, Somers R, Maertens J, Wlodarska I, Vandenberghe P, Hagemeijer A, Marynen P, Cools J (2005a): Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;!4)(q34;q32). Blood 105:4849-4852.
61. De Keersmaecker K, Marynen P, Cools J (2005b): Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 90:1116-1127.
62. Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, Le Beau MM, Rowley JD (1990): Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med 322:77-82.
63. Diccianni MB, Batova A, Yu J, Vu T, Pullen J, Amylon M, Pollock BH, Yu AL (1997): Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with pl6/pl 5 deletions. Leuk Res 21:549-558.
64. Dik WA, Brahim W, Braun C, Asnafi V, Dastugue N, Bernard OA, van Dongen JJ, Langerak AW, Macintyre EA, Delabesse E (2005): CALM-AF10 + T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia 19:1948-1957.
65. Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Sil verman GA, Kersey JH, Korsmeyer SJ (1993): Acute mixed-lineage leukemia t(4; 11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natt Acad Sci USA 90:7884-7888.
66. Downing JR, Head DR, Raimondi SC, Carroll AJ, Curcio-Brint AM, Hulshof MG, Pullen DJ, Domer PH (1994): The der(l l)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;l 1) (q21;q23)-containing acute lymphoblastic leukemia. Blood 83:330-335.
67. Drexler HG (1998): Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes pi5, p!6, pi8 and pl9 in human leukemia-lymphoma cells. Leukemia 12:845-859.
68. Dreyling MH, Schrader K, Fonatsch C, Schlegelberger B, Haase D, Schoch C, Ludwig W, Loffler H, Buchner T, Wormann B, Hiddemann W, Bohlander SK (1998): MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;ll): both rearrangements are associated with a poor prognosis. Blood 91:4662-4667.
69. Dube ID, Raimondi SC, Pi D, Kalousek DK (1986): A new translocation, t(10; 14)(q24;q 11), in T cell neoplasia. Blood 67:1181 -1184.
70. Eguchi-Ishimae M, Eguchi M, Kempski H, Greaves M (2008): NOTCH] mutation can be an early, prenatal genetic event in T-ALL. Blood 111:376-378.
71. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J (1991): TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-661.
72. Erikson J, Finger L, Sun L, Ar-Rushdi A, Nishikura K, Minowada J, Finan J, Emanuel BS, Nowell PC, Croce CM (1986): Deregulation of c-my c by translocation of the alpha-locus of T-cell receptor in T-cell leukemias. Science 232:884.
73. Fazio G, Palmi C, Rolink A, Biondi A, Cazzaniga G (2008): PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD 19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells. Cancer Res. 68:181-189.
74. Ferrando AA, Look AT (2003): Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 40:274-280.
75. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, Lander ES, Golub TR, Look AT (2002): Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75-87.
76. Ferrando AA, Herblot S, Palomero T, Hansen M, Hoang T, Fox EA, Look AT (2004a): Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood 103:1909-1911.
77. Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH, Rowe JM, Caligiuri MA, Bloomfield CD, Look AT (2004b): Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 363: 535-536.
78. Ferster A, Bertrand Y, Benoit Y, Boilletot A, Behar C, Margueritte G, Robert A, Mazingue F, Souillet G (1994): Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group. Br J Haematol 86:284-290.
79. First M1C Cooperative Study Group (1986): Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic lcukemias. Cancer Genet Cytogenet 23:189-197.
80. Fizzotti M, CiminoG, Pisegna S, AlimenaG, Quartarone C, Mandelli F. Pelicci PG, LoCoco F (1995): Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (pi6) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85:2685-2690.
81. Ford AM, Bennett CA, Price CM, Bruin MC, van Wering ER, Greaves M (1998): Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. ProcNatlAcadSci USA 95:4584-4588.
82. Forestier E, Schmiegelow K (2006): The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. J Pediatr Hematol Oncol 28:486-495.
83. Forestier E, Gauffin F, Andersen MK, Autio K, Borgstrom G, Golovleva I, Gustafsson B, Heim S, Heinonen K, Heyman M, Hovland R, Johannsson JH, Kerndrup G, Rosenquist R, Schoumans J, Swolin B, Johansson B, Nordgren A (2008a): Clinical and cytogenetic features of pediatric die (9;20)(pl3.2;q 11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Genes Chromosomes Cancer 47:149-158.
84. Forestier E, Heyman M, Andersen MK, Autio K, Blennow E, Borgstrom G, Golovleva I, Heim S, Heinonen K, Hovland R, Johannsson JH, Kerndrup G, Nordgren A, Rosenquist R, Swolin B, Johansson B (2008b): Outcome of ETV6/RUNXI-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival. Br J Haematol 140:665-672.
85. Forestier E, Izraeli S, Beverloo B, Haas O, Pession A, Michalova K, Stark B, Harrison CJ, Teigler-Schlegel A, Johansson B (2008c): Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood 111:1575-1583.
86. Frankel LS,OchsJ,ShusterJJ,DubowyR, Bowman WP, Hockenberry-EatonM, Borowitz M, Carroll AJ, Steuber CP, Pullen DJ (1997): Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493). J Pediatr Hematol Oncol 19:35-42.
87. Ganmore I, Bercovich D, Scott LM, Green AR, Cazzaniga G, Biondi A, Basso G, Cario G, Schrappe M, Stanulla M, Strehl S, Haas OA, Binder V, Borkhardt A, Trka J, Bielorei B, Avigad S, Stark B, Bourquin JP, Smith O, Kempski H, Izraeli S (2007): Collaboration Between Activating Mutations in Jak2 and Trisomy 21 in the Acute Lymphoblastic Leukemias of Down Syndrome (DS). ASH Annual Meeting Abstracts 110, LB6.
88. Gibbons B, MacCallum P, Watts E, Rohatiner AZS, Webb D, Katz FE, Seeker-Walker LM, Temperley 1J, Harrison CJ, Campbell RHA, Nash R, Broadbent V, Chessells JM (1991): Nearhaploid acute lymphoblastic leukemia: seven new cases and a review of the literature. Leukemia 5:738-743.
89. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG (1995): Fusion of the TEL gene on 12pl3 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917-4921.
90. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, Vermeesch JR, Stul M, Dutta B, Boeckx N, Bosly A, Heimann P, Uyttebroeck A, Mentens N, Somers R, MacLeod RA, DrexlerHG, Look AT, Gilliland DG, Michaux L, Vandenberghe P, Wlodarska 1, Marynen P, Hagemeijer A (2004): Fusion of NUP214 to ABLI on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 36:1084-1089.
91. Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A (2006): Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 20:1496-1510.
92. Greaves MF (2000): Molecular genetics, natural history and the demise of childhood leukaemia. EurJ Cancer 35:173-185.
93. Greaves M (2005): In utero origins of childhood leukaemia. Early Hum Dev 81:123-129.
94. Greaves MF, Maia AT, Wiemels JL, Ford AM (2003): Leukemia in twins: lessons in natural history. Blood 102:2321-2333.
95. Groffen J, Heisterkamp N (1987): The BCR/ABL hybrid gene. Baillieres Clin Haematol 1:983-999.
96. Groupe Francais de Cytogenetique Hematologique (1991): t(10; 11)(p 13-14;q 14-21): a new recurrent translocation in T-cell acute lymphoblastic leukemias. Genes Chromosomes Cancer 3:411^415.
97. Groupe Francais de Cytogenetique Hematologique (1993): Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 7:10-19.
98. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E (1992): The t (4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 11:701-708.
99. Hann 1, Vora A, Harrison G, Harrison C, Martineau M, Moorman AV, Seeker-Walker LM, Eden O, Hill F, Gibson B, Richards S (2001): Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 113:103-114.
100. Hansen-Hagge TE, Schafer M, Kiyoi H, Morris SW, Whitlock JA, Koch P, Bohlmann 1, Mahotka C, Bartram CR, Janssen JW (2002): Disruption of the RanBP17/Hox 11L2 region by recombination with the TCRdelta locus in acute iymphoblastic leukemias with t(5; 14)(q34;q 11). Leukemia 16:2205-2212.
101. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F (1997): Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 90:4933-4937.
102. Harewood L, Robinson H, Harris R, Al Obaidi MJ, Jalali GR, Martineau M, Moorman AV, Sumption N, Richards S, Mitchell C, Harrison CJ (2003): Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia 17:547-553.
103. Harris MB, Shuster JJ, Carroll A, Look AT, Borowitz MJ, Crist WM, Nitschke R, Pullen J, Steuber CP, Land VJ (1992): Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B- progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 79:3316-3324.
104. Harris RL, Harrison CJ, Martineau M, Taylor KE, Moorman AV (2004): Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia? Cancer Genet Cytogenet 148:159-162
105. Harrison CJ, (2007): Genetics of T-Cell Acute Lymphoblastic Leukemia. http://online.haematologica.org/supplements/Hematol ogy_Education _ 2007. pdf.
106. Harrison CJ, Foroni L (2002): Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev Clin Exp Hematol 6:91-113.
107. Harrison CJ, Cuneo A, Clark R, Johansson B, Lafage-Pochitaloff M, Mugneret F, Moorman AV, Seeker-Walker LM (1998): Ten novel Ilq23 chromosomal partner sites. European Ilq23 Workshop participants. Leukemia 12:811-822.
108. Harrison CJ, Moorman AV, Broadfield ZJ, Cheung KL, Harris RL, Reza JG, Robinson HM, Barber KE, Richards SM, Mitchell CD, Eden TO, Hann IM, Hill FG, Kinsey SE, Gibson BE, Lilleyman J, Vora A, Goldstone AH, Franklin M, Durrant J, Martineau M (2004): Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol 125:552-559.
109. Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL, Jalali GR, Robinson HM, Strefford JC, Stewart A, Wright S, Griffiths M, Ross FM, Harewood L, Martineau M (2005): Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol 129:520-530.
110. Hasle H, Clemmensen IH, Mikkelsen M (2000): Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355:165-169.
111. Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ (1991): Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 253:79-82.
112. Hayette S, Tigaud I, Maguer-Satta V, Bartholin L, Thomas X, Charrin C, Gadoux M, Magaud JP, Rimokh R (2002): Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood 99:4647^649.
113. Hebert J, Cayuela JM, Berkeley J, Sigaux F (1994): Candidate tumor-suppressor genes MTS1 (pl6INK4A) and MTS2 (pl5INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 84:4038-4044.
114. Heerema NA, Palmer CG, Weetman R, Bertolone S (1992): Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia. Leukemia 6:185-192.
115. Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, Zeltzer P, Hammond D, Reaman GH (1994): Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the Ilq23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood 83:2274-2284.
116. Heerema NA, Nachman JB, Sather HN, Sense! MG, Lee MK, Hutchinson R, Lange BJ, Steinherz PG, Bostrom B, Gaynon PS, Uckun F (1999a): Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood 94:4036-4045.
117. Heerema NA, Sather HN, Sensel MG, Liu-Mares W, Lange BJ, Bostrom BC, Nachman JB, Steinherz PG, Hutchinson R, Gaynon PS, Arthur DC, Uckun FM (1999b): Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 94:1537-1544.
118. Heerema NA, Sather HN, Sensel MG, Lee MK, Hutchinson RJ, Nachman JB, Reaman GH, Lange BJ, Steinherz PG, Bostrom BC, Gaynon PS, Uckun FM (2000a): Abnormalities of chromosome bands 13ql2 to 13ql4 in childhood acute lymphoblastic leukemia. J Clin Oncol 18:3837-3844.
119. Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchinson RJ, Nachman JB, Lange BJ, Steinherz PG, Bostrom BC, Reaman GH, Gaynon PS, Uckun FM (2000b): Prognostic impact of trisomies of chromosomes 10, 17 and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). J Clin Oncol 18:1876-1887.
120. Heerema NA, Sather HN, Sensel MG, La MK, Hutchinson RJ, Nachman JB, Reaman GH, Lange BJ, Steinherz PG, Bostrom BC, Gaynon PS, Uckun FM (2002): Abnormalities of chromosome bands 15ql3-15 in childhood acute lymphoblastic leukemia. Cancer 94:1102-1110.
121. Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE, McGavran L, Patil S, Pettenati MJ, Pullen J, Rao K, Roulston D, Schneider NR, Shuster JJ, Sanger W, Sutcliffe MJ, van TP, Watson MS, Carroll AJ (2007): Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes Cancer 46:684-693.
122. Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, Jones D (2008): High TCLI expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood 111:328-337.
123. Heyman M, Grander D, Brondum-Nielsen K, Liu Y, Soderhall S, Einhorn S (1993): Deletions of the short arm of chromosome 9, including the interferon-alpha/-beta genes, in acute lymphocytic leukemia. Studies on loss of heterozygosity, parental origin of deleted genes and prognosis. Int J Cancer 54:748-753.
124. Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA, McGlennen R, Smith FO, Woods WG, Salzer WL, Johnstone HS, Dreyer Z, Reaman GH (2006): Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood 108:441-451.
125. Hoshino K, Asou N, Okubo T, Suzushima H, Kiyokawa T, Kawano F, Mitsuya H (2002): The absence of the pl5INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor. Br J Haematol 117:531-540.
126. Hunger SP (1996): Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 87:1211-1224.
127. Hunger SP, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML (1991): The t(1; 19)(q23;p 13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 77:687-693.
128. Hunger SP, Devaraj PE, Foroni L, Seeker-Walker LM, Cleary ML (1994): Two types of geno- mic rearrangements create alternative E2A-HLF fusion proteins in t(17; 19)-ALL. Blood 83:2970-2977.
129. Huret JL, Brizard A, Slater R, Charrin C, Bertheas MF, Guilhot F, Kroes W, van Leeu wen E, Schoot EV (1993): Cytogenetic heterogeneity in t(ll;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients-updated published cases and 16 new observations. Leukemia 7:152-160.
130. IWCL3 Third International Workshop on Chromosomes in Leukemia (1980) (1981): Chromosomal abnormalities in acute lymphoblastic leukemia: structural and numerical changes in 234 cases. Cancer Genet Cytogenet 4:101-110.
131. IWCL3 Third International Workshop on Chromosomes in Leukemia (1980) (1983): Chromosome abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res 43:868-873.
132. Jabber Al-Obaidi MS, Martineau M, Bennett CF, Franklin IM, Goldstone AH, Harewood L, Jalali GR, Prentice HG, Richards SM, Roberts K, Harrison CJ (2002): ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 16:669-674.
133. Janssen JW, Ludwig WD, Sterry W, Bartram CR (1993): SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia 7:1204-1210.
134. Johansson B, Moorman AV, Haas OA, Watmore AE, Cheung KL, Swanton S, Seeker-Walker LM (1998): Hematologic malignancies with t(4;l I)(q21;q23)-a cytogenetic, morphologic, immuno- phenotypic and clinical study of 183 cases. Leukemia 12:779-787.
135. Kager L, Lion T, Attarbaschi A, Koenig M, Strehl S, Haas OA, Dworzak MN, Schrappe M, Gadner H, Mann G (2007): Incidence and outcome of TCF3-PBX1 -positive acute lymphoblastic leukemia in Austrian children. Haematotogica 92:1561-1564.
136. Kaleem Z, Shuster JJ, Carroll AJ, Borowitz MJ, Pullen DJ, Camitta BM, Zutter MM, Watson MS (2000): Acute lymphoblastic leukemia with an unusual t(8;14)(ql 1.2;q32): a Pediatric Oncology Group study. Leukemia 14:238-240.
137. Kardon NB, Slepowitz G, Kochen JA (1982): Childhood acute lymphoblastic leukemia associated with an unusual 8; 14 translocation. Cancer Genet Cylogenet 6:339-343.
138. Karrman K, Andersson A, Bjorgvinsdottir H, Strombeck B, Lassen C, Olofsson T, Nguyen-Khac F, Berger R, Bernard O, Fioretos T, Johansson B (2006a): Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p]3;qi l)-positive childhood T-cell acute lymphoblastic leukemia. Eur J Haematol 77:27-34.
139. Karrman K, Forestier E, Andersen MK, Autio K, Borgstrom G, Heim S, Heinonen K, Hovland R, Kerndrup G, Johansson B (2006b): High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005. Br J Haematol 135:352-354.
140. Kearney L (1999): The impact of the new FISH technologies on the cytogenetics of haematological malignancies. Br J Haematol 104:648-658.
141. Kees UR, Heerema NA, Kumar R, Watt PM, Baker DL, La MK, Uckun FM, Sather HN (2003): Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at l0q24: a study from the Children's Cancer Group (CCG). Leukemia 17:887-893.
142. Kennedy MA, Gonzalez Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH (1991): HOX11, a homebox-containing T-cell oncogene on human chromosome l0q24. Proc Natl Acad Sci USA 88:8900-8904.
143. Konrad M, Metzler M, Panzer S, Ostreicher I, Peham M, Repp R, Haas OA, Gadner H, Panzer- Grumayer ER (2003): Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood 101:3635-3640.
144. Kovacs BZ, Niggli FK, Betts DR (2004): Aberrations involving 13ql 2 approximately ql 4 are frequent secondary events in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 151:157-161.
145. Kowalczyk JP, Sandberg A (1983): A possible subgroup of ALL with 9p abnormalities. Cancer Genet Cytogenet 9:383-385.
146. Kwong YL, Wong KF (1997): Low frequency of TEL/AML1 in adult acute lymphoblastic leukemia. Cancer Genet Cytogenet 98:137-138.
147. La Starza R, Aventin A, Crescenzi B, Gorello P, Specchia G, Cuneo A, Angioni A, Bilhou-Nabera C, Boque C, Foa R, Uyttebroeck A, Talmant P, Cimino G, Martelli MF, Marynen P, Mecucci C, Hagemeijer A (2005): CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. Leukemia 19:1696-1699.
148. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA (1997): ATEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309-1312.
149. Lahortiga I, De Keersmaecker K, van Vlierberghe P, Graux C, Cauwelier B, Lambert F, Mentens N, Beverloo BH, Pieters R, Speleman F, Odero MD, Bauters F, Froyen G, Marynen P, Vandenberghe P, Wlodarska I, Meijerink JP, Cools J (2007): Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet in press.
150. Lange BJ, Raimondi SC, Heerema NA, Nowell PC, Minowada J, Steinherz PE, Arenson EB, O'Connor R, Santoli D (1992): Pediatric leukemia/lymphoma with t(8;14)(q24;ql 1). Leukemia 6:613-618.
151. Lee SY, Kumano K, Masuda S, Hangaishi A, Takita J, Nakazaki K, Kurokawa M, Hayashi Y, Ogawa S, Chiba S (2005): Mutations of the Notch 1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia 19:1841-1843.
152. Lemos JA, Defavery R, Scrideli CA, Tone LG (2003): Analysis of pi 6 gene mutations and deletions in childhood acute lymphoblastic leukemias. Sao Paulo Med J 121:58-62.
153. Lillington DM, Young BD, Berger R, Martineau M, Moorman AV, Seeker-Walker LM (1998): The t(10;l I)(pl2;q23)translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. Leukemia 12:801-804.
154. Liu S, Bo L, Liu X, Li C, Qin S, Wang J (2004): 1GH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(ql1;q32) identified by sequential R-banding and fluorescence in situ hybridization. Cancer Genet Cytogenet 152:141-145.
155. Lundin C, Heidenblad M, Strombeck B, Borg A, Hovland R, Heim S, Johansson B (2007): Tiling resolution array CGH of dic(7;9)(pl 1 approximately 13;p 11 approximately 13) in B-cell precursor acute lymphoblastic leukemia reveals clustered breakpoints at 7pl 1.2 approximately 12.1 and 9pl3.l. Cytogenet Genome Res 118:13-18.
156. Ma SK, Chan GC, Wan TS, Lam CK, Ha SY, Lau YL, Chan LC (1998): Near-haploid common acute lymphoblastic leukaemia of childhood with a second hyperdiploid line: a DNA ploidy and fluorescence in-situ hybridization study. Br J Haematol 103:750-755.
157. Mahmoud H, Carroll AJ, Behm F, Raimondi SC, Schuster J, Borowitz M, Land V, Pullen DJ, Vietti TJ, Crist W (1992): The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis. Leukemia 6:703-707.
158. Maillard I, Fang T, Pear WS (2005): Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 23:945-974.
159. Mansour MR, Linch DC, Foroni L, Goldstone AH, Gale RE (2006): High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia 20:537-539.
160. Martineau M, Clark R, Farrell DM, Hawkins JM, Moorman AV, Seeker-Walker LM (1996): [sochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding. Genes Chromosomes Cancer 17:21-30.
161. Martineau M, Berger R, Lillington DM, Moorman AV, Seeker-Walker LM (1998): The t(6; 11)(q27; q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases. EU Concerted Action Ilq23 Workshop participants. Leukemia 12:788-791.
162. Martineau M, Jalali GR, Barber KE, Broadfield ZJ, Cheung KL, Lilleyman J, Moorman AV, Richards S, Robinson HM, Ross F, Harrison CJ (2005): ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications. Genes Chromosomes Cancer 43:54-71.
163. Martini A, La Starza R, Janssen H, Bilhou-Nabera C, Corveleyn A, Somers R, Aventin A, Foa R, Hagemeijer A, Mecucci C, Marynen P (2002): Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Cancer Res 62:5408-5412.
164. Maseki N, Hayashi Y, Kaneko Y, Sakurai M (1986): Partial loss of the short arm of chromosome 9 in leukemia and lymphoma. Cancer Genet Cytogenet 22:89-91.
165. McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O' Brien SJ, Korsmeyer SJ (1989): The t(11; 14) (pl5;qll) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol 9:2124-2132.
166. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffier HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR (1996): TEL/AML-1 dimenzes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252-4258.
167. McPherson JD, Marra M, Hillier L, Waterston RH, Chinwalla A, Wallis J, Sekhon M, Wylie K, Mardis ER, Wilson RK, Fulton R, Kucaba TA, Wagner-McPherson C, Barbazuk WB, Gregory SG, Humphray SJ, French L, Evans RS, Bethel G, Whittaker A", Holden JL, McCann OT, Dunham A, Soderlund C, Scott CE, Bentley DR, Schuler G, Chen HC, Jang W, Green ED, Idol JR, Maduro VV, Montgomery KT, Lee E, Miller A, Emerling S, Kucherlapati, Gibbs R, Scherer S, Gorrell JH, Sodergren E, Clerc-Blankenburg K, Tabor P, Naylor S, Garcia D, de Jong PJ, Catanese JJ, Nowak N, Osoegawa K, Qin S, Rowen L, Madan A, Dors M, Hood L, Trask B, Friedman C, Massa H, Cheung VG, Kirsch IR, Reid T, Yonescu R, Weissenbach J, Bruls T, Heilig R, Branscomb E, Olsen A, Doggett N, Cheng JF, Hawkins T, Myers RM, Shang J, Ramirez L, Schmutz J, Velasquez O, Dixon K, Stone NE, Cox DR, Haussler D, Kent WJ, Furey T, Rogic S, Kennedy S, Jones S, Rosenthal A, Wen G, Schilhabel M, Gloeckner G, Nyakatura G, Siebert R, Schlegelberger B, Korenberg J, Chen XN, Fujiyama A, Hattori M, Toyoda A, Yada T, Park HS, Sakaki Y, Shimizu N, Asakawa S, Kawasaki K, Sasaki T, Shintani A, Shimizu A, Shibuya K, Kudoh J, Minoshima S, Ramser J, Seranski P, Hoff C, Poustka A, Reinhardt R, Lehrach H (2001): A physical map of the human genome. Nature 409:934-941.
168. Mellentin JD, Smith SD, Cleary ML (1989): ly I-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 58:77-83.
169. Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ (1994): Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukaemia. Genes Chromosomes Cancer 10:26-29.
170. Mengle-Gaw L, Albertson DG, Sherrington PD, Rabbitts TH (1988): Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome I4q32. Proc Natl Acad Sci USA 85:9171-9175.
171. Mertens F, Johansson B, Mitelman F (1994): Isochromosomes in neoplasia. Genes Chromosomes Cancer 10:221-230.
172. Meyer C, Schneider B, Jakob S, Strehl S, Attarbaschi A, Schnittger S, Schoch C, Jansen MW, van Dongen JJ, den Boer ML, Pieters R, Ennas MG, Angelucci E, Koehl U, Greil J, Griesinger F, Zur SU, Eckert C, Szczepanski T, Niggli FK, Schafer BW, Kempski H, Brady HJ, Zuna J, Trka J, Nigro LL, Biondi A, Delabesse E, Maclntyre E, Stanulla M, Schrappe M, Haas OA, Burmeister T, Dingermann T, Klingebiel T, Marschalek R (2006): The MLL recombinome of acute leukemias. Leukemia 20:777-784.
173. Michael PM, Levin MD, Garson OM (1984): Translocation 1; 19-a new cytogenetic abnormality in acute lymphocytic leukemia. Cancer Genet Cytogenet 12:333-341.
174. Mirebeau D, Acquaviva C, Suciu S, Bertin R, Robert A, Boutard P, Mechinaud F, Plouvier E, Otten J, Vilmer E, Cave H (2006): The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematobgica 91:881-885.
175. Mitelman F, Johansson B, Mertens F, editors (2008): Mitelman Database of Chromosome Aberrations in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
176. Moorman AV, Hagemeijer A, Charrin C, Rieder H, Seeker-Walker LM (1998): The translocations, t(U;19)(q23;pl3.l) and t(l I;19)(q23;pl3.3): a cytogenetic and clinical profile of 53 patients. European Ilq23 workshop participants. Leukemia 12:805-810.
177. Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR, Broadfield ZJ, Harris RL, Taylor KE, Gibson BE, Hann IM, Hill FG, Kinsey SE, Eden TO, Mitchell CD, Harrison CJ (2003): Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 102:2756-2762.
178. Moorman AV, Raimondi SC, Pui CH, Baruchel A, Biondi A, Carroll AJ, Forestier E, Gaynon PS, Harbott J, Harms DO, Heerema N, Pieters R, Schrappe M, Silverman LB, Vilmer E, Harrison CJ (2005): No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 1 Iq23 abnormalities. Leukemia 19:557-563.
179. Moorman AV, Harrison CJ, Buck GA, Richards SM, Seeker-Walker LM, Martineau M, Vance GH, Cherry AM, Higgins RR, Fielding AK, Foroni L, PaiettaE, Tallman MS, Litzow MR, Wiernik PH, Rowe JM, Goldstone AH, Dewald GW (2007a): Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXIl/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109:3189-3197.
180. Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BE, Kinsey SE, Eden TO, Vora AJ, Mitchell CD, Harrison CJ (2007b): Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood 109:2327-2330.
181. Mufti GJ, Hamblin TJ, Oscier DG, Johnson S (1983): Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations. Blood 62:1142-1146.
182. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR (2007): Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764.
183. Nachman JB, Heerema NA, Sather H, Camitta B, Forestier E, Harrison CJ, Dastugue N, Schrappe M, Pui CH, Basso G, Silverman LB, Janka-Schaub GE (2007): Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood 110:1112-1115.
184. Nagel S, Kaufmann M, Drexler HG, MacLeod RA (2003): The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B inpediatricT-ALLcell lines via a novel t(5;14)(q35.l; q32.2). Cancer Res 63:5329-5334.
185. Ohnishi H, Kawamura M, da K, Sheng XM, Hanada R, Nobori T, Yamamori S, Hayashi Y (1995): Homozygous deletions of pl6/MTS 1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood 86:1269-1275.
186. Onodera N, McCabe NR, Rubin CM (1992): Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood 80:203-208.
187. Oshimura M, Freeman AI, Sandberg AA (1977): Chromosomes and causation of human cancer and leukemia. XXVI. Banding studies in acute lymphoblastic leukemia (ALL). Cancer 40:1161-1172.
188. Pallisgaard N, Hokland P, Riishoj DC. Pederson B, Jorgensen P (1998): Multiplex reverse transcription- polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 92:574-588.
189. Paulsson K, Horvat A, Fioretos T, Mitelman F, Johansson B (2005a): Formation of der(19)t(I; 19)(q23; p]3) in acute lymphoblastic leukemia. Genes Chromosomes Cancer 42:144-148.
190. Paulsson K, Morse H, Fioretos T, Behrendtz M, Strombeck B, Johansson B (2005b): Evidence for a single-step mechanism in the origin of hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 44:113-122.
191. Paulsson K, Jonson T, Ora I, Olofsson T, Panagopoulos I, Johansson B (2007): Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1; I9)(q23;p 13)-positive acute lymphoblastic leukaemias. Br JHaematol 138:196-201.
192. Paulsson K., Horvat A, Strombeck B, Nilsson F, Heldrup J, Behrendtz M, Forestier E, Andersson A, Fioretos T, Johansson B (2008): Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 47:26-33.
193. Pellet P, Hillion J, Carroll AJ, Crist WM, Brouet JC, Tsapis A (1991): Heterogeneity of the breakpoint localization in malignant cells with a 9pll chromosomal abnormality. Leukemia 5:468^472.
194. Pieters R, Schrappe M, De LP, Hann I, De RG, Felice M, Hovi L, Leblanc T, Szczepanski T, Ferster A, Janka G, Rubnitz J, Silverman L, Stary J, Campbell M, Li CK, Mann G, Suppiah R, Biondi A, Vora A, Valsecchi MG (2007): A treatment protocol for infants younger than 1year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 370:240-250.
195. Privitera E, Camps MP, Hayashi Y, lnaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carroll AJ, Baltimore D (1992): Different molecular consequences of the 1; 19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood 79:1781-1788.
196. Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, Siebert R, Dolken G, Ludwig WD, Verhaaf B, van Dongen JJ, Schmidt CA, Langerak AW (2005): Disruption of the BCL1 IB gene through inv(14)(q 11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 19:201-208.
197. Pui C-H (1992): Acute leukemias with the t(4;l I)(q21;q23). Leuk Lymphoma 7:173-179.
198. Pui CH, Raimondi SC, Dodge RK, Rivera GK, Fuchs LA, Abromowitch M, Look AT, Furman WL, Crist WM, Williams DL (1989): Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. Blood 73:1963-1967.
199. Pui C-H, Carrol] AJ, Raimondi SC, Land VJ, Crist WM, Shuster JJ, Williams DL, Pullen J, Borowitz MJ, Behm FG, Look AT (1990): Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid orhypodiploid <45 line. Blood 75:1170-1177.
200. Pui C-H, Carroll AJ, Raimondi SC, Schell MJ, Head DR, Shuster JJ, Crist WM, Borowitz MJ, Link MP, Behm FG, Steuber CP, Land VJ (1992): Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. Blood 79:2384-2391.
201. Pui CH, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GK, Evans WE, Crist WM, Krance R (1996): Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 10:952-956.
202. Pui CH, Relling MV, Downing JR (2004): Acute lymphoblastic leukemia, N Engl J Med 350:1535-1548
203. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995): Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
204. Rabbitts TH (1994): Chromosomal translocations in human cancer. Nature 372:143-149.
205. Rabbitts TH (1998): LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev 12: 2651-2657.
206. Radich JP, Kopecky KJ, Boldt DH, Head D, Slovak ML, Babu R, Kirk J, Lee A, Kessler P, Appelbaum F, Gehly G (1994): Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia 8:1688-1695.
207. Raimondi SC, Pui CH, Head DR, Rivera G, Behm FG (1993): Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukaemia. Blood 82:576-580.
208. Raimondi SC, Pui C-H, Hancock ML, Behm FG, Filatov L, Rivera GK (1996): Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 10:213-224.
209. Raimondi SC, Zhou Y, Mathew S, Shurtleff SA, Sandlund JT, Rivera GK, Behm FG, Pui CH (2003): Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. Cancer 98:2715-2722.
210. Raimondi SC, Zhou Y, Shurtleff SA, Rubnitz JE, Pui CH, Behm FG (2006): Near-triploidy and near- tetraploidy in childhood acute lymphoblastic leukemia: association with B-lineage blast cells carrying the ETV6-RUNX1 fusion, T-lineage immunophenotype, and favorable outcome. Cancer Genet Cytogenet 169:50-57.
211. Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B (1996a): The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891-2899.
212. Raynaud SD, Mauvieux L, Cayuela JM, Bastard C, Bilhou-Nabera C, Debuire B, Bories D, Boucheix C, Charrin C, Fiere D, Gabert J (1996b): TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 10:1529-1530.
213. Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S, Raimondi SC (1999): Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)- positive acute lymphoblastic leukemia. Leukemia 13:1325-1330.
214. Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, HeeremaNA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM (1999): Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 17:445-455.
215. Rieder H, Schnittger S, Bodenstein H, Schwonzen M, Wormann B, Ludwig WD, Hoelzer D, Fonatsch C (1995): dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 13:54-61.
216. Robinson HM, Broadfield ZJ, Cheung KL, Harewood L, Harris RL, Jalali GR, Martineau M, Moorman AV, Taylor KE, Richards S, Mitchell C, Harrison CJ (2003): Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia 17:2249-2250.
217. Robinson HM, Taylor KE, Jalali GR, Cheung KL, Harrison CJ, Moorman AV (2004): t(14;19)(q32; ql 3): a recurrent translocation in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 39:88-92.
218. Robinson HM, Martineau M, Harris RL, Barber KE, Jalali GR, Moorman AV, Strefford JC, Broadfield ZJ, Cheung KL, Harrison CJ (2005): Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia. Leukemia 19:564-571.
219. Robinson HM, Harrison CJ, Moorman AV, Chudoba I, Strefford JC (2007): Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle. Genes Chromosomes Cancer 46:318-326.
220. Romana SP, Le Coniat M, Berger R (1994): t(l2;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9:186-191.
221. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA (1995a): The t(12;2l) of acute lymphoblastic leukemia results in a tel-AMLl gene fusion. Blood 85:3662-3670.
222. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux R, Berger R, Bernard OA (1995b): High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263-4269.
223. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A, Downing JR (2003): Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102:2951-2959.
224. Rowley JD, Diaz MO, Espinosa R III, Patel Y, Van Melle E, Ziemin S, Taillon-Miller P, Lichter P, Evans GA, Kersey JH, Ward DC, Dommer PH, Le Beau MM (1990): Mapping chromosome band 1 Iq23 in human acute leukemia with biotinlated probes: identification of 1 Iq23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 87:9358-9362.
225. Royer-Pokora B, Loos U, Ludwig WD (1991): TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(ll;14)(pl3;ql 1). Oncogene 6:1887-1893.
226. Russell LJ, Akasaka T, Majid A, Sugimoto KJ, Loraine KE, Nagel L Harder L, Claviez A, Gesk S, Moorman AV, Ross F, Mazzullo H, Strefford JC, Siebert R, Dyer MJ, Harrison CJ (2008): t(6;\4) (p22;q32): a new recurrent IGH translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 111:387-391.
227. Schaad K, Strombeck B, Mandahl N, Andersen MK, Heim S, Mertens F, Johansson B (2006): FISH mapping of i(7q) in acute leukemias and myxoid liposarcoma reveals clustered breakpoints in 7pl 1.2: implications for formation and pathogenetic outcome of the idic(7)(pl 1.2). Cytogenet Genome Res 114:126-130.
228. Schoumans J, Johansson B, Corcoran M, KuchinskayaE, Golovleva 1, Grander D, Forestier E, Staaf J, Borg A, Gustafsson B, Blennow E, Nordgren A (2006): Characterisation of dic(9;20)(pI l-13;qll) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9pl3.2 and 20ql 1.2. Br J Haematol 135:492-499.
229. Schultz KR, Bowman WP, Slayton W, Aledo A, Devidas M, Sather H, Borowitz MJ, Davies SM, Trigg M, Pasut B, Jorstad D, Eslinger T, Burden LE, Wang C, Rutledge R, Gaynon PS, Carroll AJ, Heerema NA, Winick N, Hunger S, Carroll WL, Camitta B (2007a): Improved early event free survival (EFS) in children with Philadelphia chromosome-positive (Ph -f) acute lymphoblastic leukemia (ALL) with intensive imatinib in combination with high dose chemotherapy: Children's Oncology Group (COG) Study AALL003I. ASH Annual Meeting Abstracts 110:4.
230. Schultz KR, Pullen DJ, Sather HN, Shuster JJ, Devidas M, Borowitz MJ, Carroll AJ, Heerema NA, Rubnitz JE, Loh ML, Raetz EA, Winick NJ, Hunger SP. Carroll WL, Gaynon PS, Camitta BM (2007b): Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 109:926-935.
231. Seeker-Walker LM, (1997): Chromosomes andGenes in Acute Lymphoblastic Leukaemia. New York: Chapman and Hall.
232. Seeker-Walker LM, Lawler SD, Hardisty RM (1978): Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. Br Med J 2:1529-1530.
233. Seeker-Walker LM, Chessells JM, Stewart EL, Swansbury GJ, Richards S, Lawler SD (1989): Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. Br J Haematol 72:336-342.
234. Seeker-Walker LM, Berger R, Fenaux P, Lai JL, Nelken B, Garson M, Michael PM, Hagemeijer A, Harrison CJ, Kaneko Y, Rubin CM (1992): Prognostic significance of the balanced t(l;19) and unbalanced der(l9)t(1;l9) translocations in acute lymphoblastic leukemia. Leukemia 6:363-369.
235. Shearer BM, Flynn HC, Knudson RA, Ketterling RP (2005): Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(l;19)(q23;pl3.3) or t(l;19)(q23;pl3. 3) in paediatric patients with acute lymphoblastic leukaemia. Br J Haematol 129:45-52.
236. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC-H, Pui C-H, Grosveld G, Downing JR (1995): TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985-1989.
237. Sinclair PB, Sorour A, Martineau M, Harrison CJ, Mitchell WA, O'Neill E, Foroni L (2004): A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res 64:4089-4098.
238. Slater R, Smit E, Kroes W, Jotterand Bellomo M, Muhlematter D, Harbott J, Behrendt H, Hahlen K, Veerman AJP, Hagemeijer A (1995): A non-random chromosome abnormality found in precusor-B lineage acute lymphoblastic leukaemia: dic(9;20)(pl?3;ql 1). Leukemia 9:1613-1619.
239. Slater RM, von Drunen E, Kroes WG, Weghuis DO, van den BE, Smit EM, Does-van den Berg A, van Wering E, Hahlen K, Carroll AJ, Raimondi SC, Beverloo HB (2001): t(7;12)(q36;pl3) and t(7;12) (q32;pl3)-translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia 15:915-920.
240. Soenen V, Lepelley P, Gyan E, Preudhomme C, Lai JL, Bauters F, Fenaux P, Quesnel B (2001): Prognostic significance of pl6INK4a immunocytochemistry in adult ALL with standard risk karyotype. Leukemia 15:1054-1059.
241. Soler G, Radford-Weiss I, Ben-Abdelali R, Mahlaoui N, Ponceau JF, Macintyre EA, Vekemans M, Bernard OA, Romana SP (2008) Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation. Leukemia 22:1278-1280.
242. Soulier J, Trakhtenbrot L, Najfeld V, Lipton JM, Mathew S, Avet-Loiseau H, De Braekeleer M, Salem S, Baruchel A, Raimondi SC, Raynaud SD (2003): Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup. Leukemia 17:1679-1682.
243. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombrel H, Baruchel A, Toribio ML, Sigaux F (2005): HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 106:274-286.
244. Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B, Van Roy N, Vandesompele J, Graux C, Uyttebroeck A, Boogaerts M, De Moerloose B, Benoit Y, Selleslag D, Billiet J, Robert A, Huguet F, Vandenberghe P, De Paepe A, Marynen P, Hagemeijer A (2005): A new recurrent inversion, inv(7)(pl5q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia 19:358-366.
245. Stark B, Jeison M, Gobuzov R, Krug H, Glaser-Gabay L, Luria D, El Hasid R, Harush MB, Avrahami G, Fisher S, Stein J, Zaizov R, Yaniv I (2001): Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line: detection by fluorescence in situ hybridization. Cancer Genet Cytogenel 128:108-113.
246. Stergianou K, Fox C, Russell NH (2005): Fusion of NUP214 to ABL1 on amplified episomes in T-ALL-implications for treatment. Leukemia 19:1680-1681.
247. Strefford JC, Van Delft FW, Robinson HM, Worley H, Yiannikouris O, Selzer R, Richmond T, Hann I, Bellotti T, Raghavan M, Young BD, Saha V, Harrison CJ (2006): Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Proc Natl Acad Sci USA 103:8167-8172.
248. Strefford JC, Worley H, Barber K, Wright S, Stewart AR, Robinson HM, Bettney G, Van Delft FW, Atherton MG, Davies T, Griffiths M, Hing S, Ross FM, Talley P, Saha V, Moorman AV, Harrison CJ (2007): Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 26:4306-4318.
249. Strehl S, Konig M, Dworzak MN, Kalwak K, Haas OA (2003): PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(pl3;pl3). Leukemia 17:1121-1123.
250. Su XY, Busson M, V, Delia V, Ballerini P, Dastugue N, Talmant P, Ferrando AA, Baudry-Bluteau D, Romana S, Berger R, Bernard OA (2004): Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 41:243-249.
251. Su X, Drabkin H, Clappier E, Morgado E, Busson M, Romana S, Soulier J, Berger R, Bernard OA, Lavau C (2006a): Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer 45:846-855.
252. Su XY, la-Valle V, ndre-Schmutz I, Lemercier C, Radford-Weiss I, Ballerini P, Lessard M, Lafage-Pochitaloff M, Mugneret F, Berger R, Romana SP, Bernard OA, Penard-Lacronique V (2006b): HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL1 IB as a result of the t(5;14)(q35;q32). Blood 108:4198^201.
253. Tanabe S, Bohlander SK, Vignon CV, Espinosa R 111, Zhao N, Strissel PL, Zeleznik-Le NJ, Rowley JD (19%): AF10 is split by MLL and HEAB, a human homolog to a putative Caenorhabditis elegans ATP/GTP-binding protein in an invins(10;ll)(pl2;q23ql2). Blood 88:3535-3545.
254. Testoni N, Zaccaria A, Martinelli G, Pelliconi S, Buzzi M. Farabegoli P, Panzica G, Tura S (1993): t (8; 14)(ql 1;q32) in acute lymphoid leukemia: description of two cases. Cancer Genet Cytogenel 67:55-58.
255. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD (1994): Cloning of ELL, a gene that fuses to MLL in a t(l I;19)(q23;pl3.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 91:12110-12114.
256. Tosi S, Harbott J, Teigler-Schlegel A, Haas OA, Pirc-Danoewinata H, Harrison CJ, Biondi A, Cazzaniga G, Kempski H, Scherer SW, Kearney L (2000): t(7;12)(q36;p!3), a new recurrent translocation involving ETV6 in infant leukemia. Genes Chromosomes Cancer 29:325-332.
257. UKCCG United Kingdom Cancer Cytogenetics Group (1992): Translocations involving 12p in acute myeloid leukemia: association with prior myelodysplasia and exposure to mutagenic agents. Genes Chromosomes Cancer 5:252-254.
258. Van den Berghe H, David G, Broeckaert-Van OA, Louwagie A, Verwilghen R, Casteels-Van DM, Eggermont E, Eeckels R (1979): A new chromosome anomaly in acute lymphoblastic leukemia (ALL). Hum Genet 46:173-180.
259. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K, Langerak AW, van Dongen JJ (2004): Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 18:895-908.
260. van Oostveen J, Bijl J, Raaphorst F, Walboomers J, Meijer C (1999): The role of homeobox genes in normal hematopoiesis and hematological malignancies. Leukemia 13:1675-1690.
261. Van Rhee F, Kasprzyk A, Jamil A, Dickinson H, Lin F, Cross NCP, Galvin MC, Goldman JM, Seeker-Walker LM (1995): Detection of the BCR-ABL gene by reverse transcription/polymerase chain reaction and fluorescence in situ hybridization in a patient with Philadelphia chromosome negative acute lymphoblastic leukaemia. Br J Haematol 90:225-228.
262. van Vlierberghe P, van GM, Beverloo HB, Lee C, Heigason T, Buijs-Gladdines J, Passier M, van Wering ER, Veerman AJ, Kamps WA, Meijerink JP, Pieters R (2006): The cryptic chromosomal deletion del(ll)(pl2pl3) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 108:3520-3529.
263. Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F, Thompson B, Spaulding C, Macaroun S, Alegre ML, Kee BL, Ferrando A, Miele L, Aifantis I (2007): Targeting the NF-kappaB signaling pathway in Notch 1-induced T-cell leukemia. Nat Med 13:70-77.
264. von Bergh AR, van DE, van Wering ER, van Zutven LJ, Hainmann I, Lonnerholm G, Meijerink JP, Pieters R, Beverloo HB (2006): High incidence of t(7; 12)(q36;p 13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9, Genes Chromosomes Cancer 45:731-739
265. Wada M, Bartram CR, Nakamura H, Hachiya M, Chen DL, Borenstein J, Miller CW, Ludwig L, Hansen-Hagge TE, Ludwig WD (1993): Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. jBtoo^82:3163-3l69.
266. Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, Hitomi J, Yamamoto T, Utsuyama M, Niwa O, Aizawa S, Kominami R (2003): Bell lb is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol 4:533-539.
267. Wang J, Jani-Sait SN, Escalon EA, Carroll AJ, de Jong PJ, Kirsch IR, Apian PD (2000): The t(14;21) (qll.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci USA 97:3497-3502.
268. Weng AP, Ferrando AA, Lee W, Morris JP, Sil verman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC (2004): Activating mutations of NOTCH 1 in human T cell acute lymphoblastic leukemia. Science 306:269-271.
269. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Del BC, Rodriguez CG, Sai H, Tobias J, Li Y, Wolfe MS, Shachaf C, Felsher D, Blacklow SC, Pear WS, Aster JC (2006): c-Myc is an important direct target of Notch! in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 20:2096-2109.
270. Williams DL, Look AT, Melvin SL, Roberson PK, Dahl G, Flake T, Stass S (1984): New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 36:101-109.
271. Xia Y, Brown L, YangCY, Tsan JT, Siciliano MJ, Espinosa R III, LeBeau MM, Baer RJ (1991): TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci USA 88:11416-11420.
272. Yamada Y, Hatta Y, Murata K, Sugawara K, Ikeda S, Mine M, Maeda T, Hirakata Y, Kamihira S, Tsukasaki K, Ogawa S, Hirai H, Koeffler HP, Tomonaga M (1997): Deletions of pl5and/or pl6 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 15:1778-1785.
273. Yamamoto K, Seto M, Komatsu H, lida S, Akao Y, Kojima S, Kodera Y, Nakazawa S, Ariyoshi Y, Takahashi T (1993): Two distinct portions of LTG19/ENL at 19pl3 are involved in t(ll;19) leukemia. Oncogene 8:26)7-2625.
274. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR (2002): Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133-143.
275. Zhong CH, Prima V, Liang X, Frye C, McGavran L, Meltesen L, Wei Q, Boomer T, Varella-Garcia M, Gump J, Hunger SP (2008): E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19) (pl3.3; pl3. 3) in acute leukemia. Leukemia 22:723-729.
276. Zhou M, Gu L, Yeager AM, Findley HW (1997): Incidence and clinical significance of CDKN2/ MTS l/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 14:141-150.
277. Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J, Gao XD, Chen B, Li JM, Xiong SM, Gu LJ, Tang JY, Liang H, Jiang H, Xue YQ, Shen ZX, Chen Z, Chen SJ (2006): NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogene- sis. Clin Cancer Res 12:3043-3049.
278. Zuna J, Muzikova K, Hrusak O, Stary J, Trka J (2002): Significance of real-time quantitative PCR detection of pl6 gene deletions in childhood acute lymphoblastic leukemia. Haematologica 87:668-669.